Source: FactSet Data are provided 'as is' for informational purposes only and are not intended for trading purposes.
The Company, through its subsidiaries, focuses manufacturing and distribution animal health and nutrition products, as well as veterinary pharmaceuticals.
Is YENHER a profitable investment? The Manufacturing segment includes feed additives and other animal nutrition products; veterinary pharmaceuticals and vaccines; and raw materials and commodities.
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.
In recent years, Yenher has been growing its higher margin manufacturing segment and promoting in-house manufactured products.
According to present data YENHER's 5300 shares and potentially its market environment have been in bearish cycle last 12 months if exists.